On Tuesday, announcing the Novartis joint venture buyout, she said the proposed deal would «allow GSK shareholders to capture the full value of one of the world's leading consumer healthcare businesses.» (fortune.com)
Most of the brands came from its acquisition of Wyeth, having sold its old consumer healthcare business to Johnson & Johnson (NYSE: JNJ) in 2006. (fool.com)
Remember yesterday, when it was reported that GlaxoSmithKline had outbid Reckitt Benckiser for Pfizer's consumer healthcare business? (fortune.com)